DOI: 10.1055/s-00033990

TH Open

Referenz

Dawwas GK, Brown J, Dietrich E, Park H.
Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis.

Lancet Haematol 2019;
6 (01) e20-e28

Bibliographische Angaben herunterladen

Aufrufen in: